Marie Bradley, PhD, MPharm, MSc.PH

Senior Advisor, RWE Analytics
RWE Analytics, CDER, Food and Drug Administration
Silver Spring, Maryland, United States

Disclosure information not submitted.

Presentation(s):

• SW-2A - Real-World Evidence in Regulatory Decision-Making for Medical Products

  Sunday, August 24, 2025
  5:15 PM - 6:45 PM ET

• 3A-01 - Cardiovascular Effectiveness of Semaglutide: Using Real-World Data to Predict Findings of the Ongoing SOUL Cardiovascular Outcomes Trial

  Monday, August 25, 2025
  8:15 AM - 8:30 AM ET

• SW-4B - Real-world evidence fit for regulatory applications — what does good look like?

  Tuesday, August 26, 2025
  10:30 AM - 12:00 PM ET

• 6C-03 - Using Real-World Data to Predict Findings of an Ongoing Phase IV Trial: Glycemic Control of Semaglutide vs Standard of Care

  Tuesday, August 26, 2025
  2:00 PM - 2:15 PM ET